Loading chat...
GA HR1160
Resolution
Status
Engrossed
3/27/2018
Primary Sponsor
Dewayne Hill
Click for details
AI Summary
- Creates the House Study Committee on Risks Associated with Kratom, composed of three members of the Georgia House of Representatives appointed by the Speaker, to study the use, risks, and potential need for state action regarding kratom
- Notes that kratom is marketed as an opioid painkiller replacement and addiction treatment, and is found in unregulated supplements as a concentration booster and workout enhancer
- Cites FDA Commissioner Scott Gottlieb's February 6, 2018, declaration that kratom is an opioid, with evidence of similar risks of abuse, addiction, and death as narcotics
- References a ten-fold increase in U.S. poison control center calls related to kratom from 2010 to 2015, and notes kratom is already banned in five U.S. states (Alabama, Arkansas, Indiana, Tennessee, and Wisconsin)
- Committee members may receive allowances for up to five days unless additional days are authorized, funded from House of Representatives appropriations, with the committee set to be abolished on December 1, 2018
Legislative Description
House Study Committee on Risks Associated with Kratom; create
Last Action
House Passed/Adopted
3/27/2018
Full Bill Text
No bill text available